for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CSPC Pharmaceutical Group Ltd

1093.HK

Latest Trade

18.70HKD

Change

-0.22(-1.16%)

Volume

9,500,257

Today's Range

18.50

 - 

18.96

52 Week Range

11.22

 - 

21.80

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

CSPC Pharmaceutical Group Says FY Prelim Net Profit Attributable Expected To Increase By 15% To 30%

Jan 22 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC PHARMACEUTICAL GROUP LTD - FY PRELIM NET PROFIT ATTRIBUTABLE EXPECTED TO INCREASE BY 15% TO 30% VERSUS LAST YEAR.

Cspc Pharmaceutical Group Says Sunitinib Malate Capsules Developed By Unit Granted Drug Registration Approval

Jan 2 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::SUNITINIB MALATE CAPSULES DEVELOPED BY UNIT GRANTED DRUG REGISTRATION APPROVAL BY NMPA OF PRC.

Cspc Pharmaceutical Says Tablets Granted Drug Registration Approval By NMPA

Jan 2 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::PRAMIPEXOLE DIHYDROCHLORIDE TABLETS DEVELOPED BY UNIT GRANTED DRUG REGISTRATION APPROVAL BY NMPA OF PRC.

CSPC Pharmaceutical Group Announces Termination Of Product Co-Development & Strategic Collaboration Agreement

Dec 30 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC PHARMACEUTICAL GROUP ANNOUNCES TERMINATION OF PRODUCT CO-DEVELOPMENT & STRATEGIC COLLABORATION AGREEMENT WITH SHANGHAI JUNSHI BIOSCIENCES.

CSPC Pharmaceutical Group Says "Pregabalin Capsules" Granted ANDA Approval by U.S. FDA

Dec 30 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::ABBREVIATED NEW DRUG APPLICATION OF GROUP'S PRODUCT "PREGABALIN CAPSULES" GRANTED APPROVAL BY U.S. FDA.

Cspc Pharmaceutical Group Says Conjupri (Levoamlodipine Maleate) Tablets Received Marketing Approval

Dec 20 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CONJUPRI (LEVOAMLODIPINE MALEATE) TABLETS RECEIVED MARKETING APPROVAL FROM U.S. FOOD AND DRUG ADMINISTRATION.

CSPC Pharmaceutical Group Says Ibuprofen Tablets Granted Approval By NMPA

Dec 11 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC PHARMACEUTICAL GROUP- IBUPROFEN TABLETS (0.1G) DEVELOPED BY UNIT HAS BEEN GRANTED APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC.

CSPC Pharmaceutical Says Cefixime Capsules (0.1G) Granted Approval By NMPA

Nov 27 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CEFIXIME CAPSULES (0.1G) GRANTED APPROVAL BY NMPA FOR PASSING CONSISTENCY OF QUALITY & EFFICACY EVALUATION OF GENERIC DRUGS.

CSPC Pharmaceutical Group Says 9-Month Profit Attributable RMB2.81 Bln

Nov 18 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::9-MONTH PROFIT ATTRIBUTABLE RMB 2.81 BILLION, UP 24%.9-MONTH TOTAL REVENUE RMB16.76 BILLION, UP 27.5%.

CSPC Pharmaceutical Announces Passing Of Consistency Evaluation For "Cephalexin Capsules"

Nov 1 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::ANNOUNCES PASSING OF CONSISTENCY EVALUATION FOR GROUP'S "CEPHALEXIN CAPSULES".

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up